{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:23:52Z","timestamp":1786983832235,"version":"build-2736575974"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Biochemistry and Biophysics"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.abb.2022.109415","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T06:03:00Z","timestamp":1664258580000},"page":"109415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Sacubitril\/valsartan attenuates myocardial ischemia\/reperfusion injury via inhibition of the GSK3\u03b2\/NF-\u03baB pathway in cardiomyocytes"],"prefix":"10.1016","volume":"730","author":[{"given":"Fangping","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2592-1669","authenticated-orcid":false,"given":"Mei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.abb.2022.109415_bib1","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1606915","article-title":"Acute myocardial infarction","volume":"376","author":"Anderson","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.abb.2022.109415_bib2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/eurheartj\/ehv592","article-title":"Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments","volume":"37","author":"Montecucco","year":"2016","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.abb.2022.109415_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","article-title":"Optimized treatment of ST-elevation myocardial infarction","volume":"125","author":"Niccoli","year":"2019","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.abb.2022.109415_bib4","first-page":"774","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge","volume":"38","author":"Heusch","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.abb.2022.109415_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1 Suppl","key":"10.1016\/j.abb.2022.109415_bib6","first-page":"I270","article-title":"Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury","volume":"114","author":"Shimamoto","year":"2006","journal-title":"Circulation"},{"issue":"1\u20132","key":"10.1016\/j.abb.2022.109415_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","article-title":"30 Years of NF-\u03baB: a blossoming of relevance to human pathobiology","volume":"168","author":"Zhang","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.abb.2022.109415_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/cvr\/cvy163","article-title":"Cardiomyocyte-specific deficiency of HSPB1 worsens cardiac dysfunction by activating NF\u03baB-mediated leucocyte recruitment after myocardial infarction","volume":"115","author":"Wang","year":"2019","journal-title":"Cardiovasc. Res."},{"issue":"16","key":"10.1016\/j.abb.2022.109415_bib9","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2174\/1389450119666180219120534","article-title":"NF-\u03baB-IKK\u03b2 pathway as a target for drug development: realities, challenges and perspectives","volume":"19","author":"Freitas","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"10.1016\/j.abb.2022.109415_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells9040820","article-title":"GSK3: a kinase balancing promotion and resolution of inflammation","volume":"9","author":"Hoffmeister","year":"2020","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.abb.2022.109415_bib11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00395-009-0043-1","article-title":"Angiotensin type 1 receptor mediates thyroid hormone-induced cardiomyocyte hypertrophy through the Akt\/GSK-3beta\/mTOR signaling pathway","volume":"104","author":"Diniz","year":"2009","journal-title":"Basic Res. Cardiol."},{"issue":"1","key":"10.1016\/j.abb.2022.109415_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1124\/jpet.113.203927","article-title":"Selective kinin receptor agonists as cardioprotective agents in myocardial ischemia and diabetes","volume":"346","author":"Potier","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.abb.2022.109415_bib13","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3389\/fphar.2019.01493","article-title":"Angiotensin II type I receptor antagonism attenuates nicotine-induced cardiac remodeling, dysfunction, and aggravation of myocardial ischemia-reperfusion injury in rats","volume":"10","author":"Ramalingam","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.abb.2022.109415_bib14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.yjmcc.2011.02.012","article-title":"Angiotensin-II type 1 receptor and NOX2 mediate TCF\/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy","volume":"50","author":"Shanmugam","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"20","key":"10.1016\/j.abb.2022.109415_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1136\/heartjnl-2017-311295","article-title":"Sacubitril\/valsartan: beyond natriuretic peptides","volume":"103","author":"Singh","year":"2017","journal-title":"Heart"},{"issue":"10","key":"10.1016\/j.abb.2022.109415_bib16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2015.01.033","article-title":"The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure","volume":"65","author":"Braunwald","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.abb.2022.109415_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ejhf.1675","article-title":"Angiotensin-neprilysin inhibition in de novo heart failure - starting off strong","volume":"22","author":"Bhatt","year":"2020","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.abb.2022.109415_bib18","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"PARADIGM-HF Investigators and Committees, Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.abb.2022.109415_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8948657","article-title":"MicroRNA-145 protects against myocardial ischemia reperfusion injury via CaMKII-mediated antiapoptotic and anti-inflammatory pathways","volume":"2019","author":"Liu","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"19","key":"10.1016\/j.abb.2022.109415_bib20","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.jacc.2018.07.102","article-title":"Sacubitril\/valsartan averts adverse post-infarction ventricular remodeling and preserves systolic function in rabbits","volume":"72","author":"Torrado","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1\u20136","key":"10.1016\/j.abb.2022.109415_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2119\/2004-00032.Aneja","article-title":"Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats","volume":"10","author":"Aneja","year":"2004","journal-title":"Mol. Med."},{"issue":"9","key":"10.1016\/j.abb.2022.109415_bib22","doi-asserted-by":"crossref","first-page":"H1884","DOI":"10.1152\/ajpheart.00967.2011","article-title":"Myocardial infarction impairs renal function, induces renal interstitial fibrosis, and increases renal KIM-1 expression: implications for cardiorenal syndrome","volume":"302","author":"Lekawanvijit","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.abb.2022.109415_bib23","article-title":"Inhibition of microRNA-327 ameliorates ischemia\/reperfusion injury-induced cardiomyocytes apoptosis through targeting apoptosis repressor with caspase recruitment domain","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.abb.2022.109415_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.118.036044","article-title":"Dectin-1 contributes to myocardial ischemia\/reperfusion injury by regulating macrophage polarization and neutrophil infiltration","volume":"139","author":"Fan","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.abb.2022.109415_bib25","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41392-022-01054-3","article-title":"Cardiomyocyte-specific knockout of ADAM17 ameliorates left ventricular remodeling and function in diabetic cardiomyopathy of mice","volume":"7","author":"Xue","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.abb.2022.109415_bib26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1080\/15548627.2019.1586246","article-title":"METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia\/reoxygenation-treated cardiomyocytes","volume":"15","author":"Song","year":"2019","journal-title":"Autophagy"},{"issue":"11","key":"10.1016\/j.abb.2022.109415_bib27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCULATIONAHA.115.018622","article-title":"Combined angiotensin receptor antagonism and neprilysin inhibition","volume":"133","author":"Hubers","year":"2016","journal-title":"Circulation"},{"issue":"1\u20132","key":"10.1016\/j.abb.2022.109415_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11010-015-2513-0","article-title":"Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: role of ROS and NF-\u03baB","volume":"409","author":"Gopi","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.abb.2022.109415_bib29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.mce.2015.04.028","article-title":"Molecular mechanisms underlying oxytocin-induced cardiomyocyte protection from simulated ischemia-reperfusion","volume":"412","author":"Gonzalez-Reyes","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"1","key":"10.1016\/j.abb.2022.109415_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00019606-200603000-00009","article-title":"Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts","volume":"15","author":"Arocho","year":"2006","journal-title":"Diagn. Mol. Pathol."},{"key":"10.1016\/j.abb.2022.109415_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pharmthera.2016.07.004","article-title":"Pharmacology of heart failure: from basic science to novel therapies","volume":"166","author":"Lother","year":"2016","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.abb.2022.109415_bib32","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/CS20150469","article-title":"The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment","volume":"130","author":"Volpe","year":"2016","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.abb.2022.109415_bib33","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jamacardio.2018.3789","article-title":"Bioactive signaling in next-generation pharmacotherapies for heart failure: a review","volume":"3","author":"Oatmen","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"6","key":"10.1016\/j.abb.2022.109415_bib34","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacbts.2017.08.001","article-title":"Cardioprotective effects of LCZ696 (Sacubitril\/Valsartan) after experimental acute myocardial infarction","volume":"2","author":"Ishii","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"issue":"5","key":"10.1016\/j.abb.2022.109415_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008268","article-title":"Combined angiotensin receptor-neprilysin inhibitors improve cardiac and vascular function via increased NO bioavailability in heart failure","volume":"7","author":"Trivedi","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"9932","key":"10.1016\/j.abb.2022.109415_bib36","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0140-6736(14)60107-0","article-title":"Cardiovascular remodelling in coronary artery disease and heart failure","volume":"383","author":"Heusch","year":"2014","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.abb.2022.109415_bib37","doi-asserted-by":"crossref","first-page":"H1553","DOI":"10.1152\/ajpheart.00158.2018","article-title":"Inflammasome, pyroptosis, and cytokines in myocardial ischemia-reperfusion injury","volume":"315","author":"Toldo","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"8","key":"10.1016\/j.abb.2022.109415_bib38","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/CIRCRESAHA.119.315216","article-title":"Transplantation of human umbilical cord blood-derived cellular fraction improves left ventricular function and remodeling after myocardial ischemia\/reperfusion","volume":"125","author":"Zhao","year":"2019","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.abb.2022.109415_bib39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.tcb.2015.03.003","article-title":"Surviving apoptosis: life-death signaling in single cells","volume":"25","author":"Flusberg","year":"2015","journal-title":"Trends Cell Biol."},{"issue":"1","key":"10.1016\/j.abb.2022.109415_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/imr.12550","article-title":"The interplay of IKK, NF-\u03baB and RIPK1 signaling in the regulation of cell death, tissue homeostasis and inflammation","volume":"277","author":"Kondylis","year":"2017","journal-title":"Immunol. Rev."},{"issue":"25","key":"10.1016\/j.abb.2022.109415_bib41","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1161\/01.CIR.0000150537.59754.55","article-title":"Nuclear factor-kappaB represses hypoxia-induced mitochondrial defects and cell death of ventricular myocytes","volume":"110","author":"Regula","year":"2004","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/j.abb.2022.109415_bib42","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1161\/01.CIR.0000108929.93074.0B","article-title":"Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction","volume":"108","author":"Misra","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.abb.2022.109415_bib43","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.biopha.2018.07.015","article-title":"Involvement of JNK1\/2-NF-\u03baBp65 in the regulation of HMGB2 in myocardial ischemia\/reperfusion-induced apoptosis in human AC16 cardiomyocytes","volume":"106","author":"Zhang","year":"2018","journal-title":"Biomed. pharmacother. Biom\u00e9d. pharmacoth\u00e9r."},{"issue":"6","key":"10.1016\/j.abb.2022.109415_bib44","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1159\/000493817","article-title":"Pim1 overexpression prevents apoptosis in cardiomyocytes after exposure to hypoxia and oxidative stress via upregulating cell autophagy","volume":"49","author":"Zhu","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.abb.2022.109415_bib45","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fphar.2017.00464","article-title":"Attenuation of TNF-\u03b1-Induced inflammatory injury in endothelial cells by ginsenoside Rb1 via inhibiting NF-\u03baB, JNK and p38 signaling pathways","volume":"8","author":"Zhou","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.abb.2022.109415_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.111774","article-title":"The long noncoding RNA NKILA protects against myocardial ischaemic injury by enhancing myocardin expression via suppressing the NF-\u03baB signalling pathway","volume":"387","author":"Liu","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.abb.2022.109415_bib47","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bbrc.2017.06.190","article-title":"BCL-2 proteins and apoptosis: recent insights and unknowns","volume":"500","author":"Edlich","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.abb.2022.109415_bib48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jep.2010.05.038","article-title":"Carthamus tinctorius L. prevents LPS-induced TNFalpha signaling activation and cell apoptosis through JNK1\/2-NFkappaB pathway inhibition in H9c2 cardiomyoblast cells","volume":"130","author":"Tien","year":"2010","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.abb.2022.109415_bib49","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/cvr\/cvx049","article-title":"Novel targets and future strategies for acute cardioprotection: position paper of the European society of cardiology working group on cellular biology of the heart","volume":"113","author":"Hausenloy","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.abb.2022.109415_bib50","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1253\/jcj.62.680","article-title":"Effect of chronic neutral endopeptidase inhibition on cardiac hypertrophy after experimental myocardial infarction","volume":"62","author":"Yoshida","year":"1998","journal-title":"Jpn. Circ. J."},{"issue":"1","key":"10.1016\/j.abb.2022.109415_bib51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0022-3565(24)38136-4","article-title":"Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels","volume":"289","author":"Duncan","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["Archives of Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122003009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003986122003009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T06:26:07Z","timestamp":1757744767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003986122003009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":51,"alternative-id":["S0003986122003009"],"URL":"https:\/\/doi.org\/10.1016\/j.abb.2022.109415","relation":{},"ISSN":["0003-9861"],"issn-type":[{"value":"0003-9861","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sacubitril\/valsartan attenuates myocardial ischemia\/reperfusion injury via inhibition of the GSK3\u03b2\/NF-\u03baB pathway in cardiomyocytes","name":"articletitle","label":"Article Title"},{"value":"Archives of Biochemistry and Biophysics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abb.2022.109415","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109415"}}